Cisatracurium
CISATRACURIUM BESYLATE
- Strength
- 2 mg/mL
- Form
- Injection, Solution
- Class
- Nondepolarizing Neuromuscular Blocker
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Listed by Hikma Pharmaceuticals USA Inc.
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Nondepolarizing Neuromuscular Blocker |
| Approval route | ANDA — approved generic |
| NDC code | 0143-9396 |
| FDA application | ANDA203078 |
| RxNorm concept | 199212 |
| Package sizes listed | 1 |
| Marketed since | May 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
CISATRACURIUM BESYLATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
CISATRACURIUM BESYLATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
CISATRACURIUM BESYLATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Meitheal Pharmaceuticals Inc.
Not stocked by us — reference only
Camber Pharmaceuticals Inc.
Not stocked by us — reference only
Camber Pharmaceuticals Inc.
Not stocked by us — reference only
Eugia US LLC
Not stocked by us — reference only
Caplin Steriles Limited
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.